Álvarez-Román, M. T., I. Cuervo-Arango, R. Pérez-Santamarina, J. L. Poveda, J. A. Romero, A. Santamaría, J. L. Trillo-Mata, M. Tort, and X. Badia. “Determining the Value Contribution of Emicizumab (Hemlibra®) for the Prophylaxis of Haemophilia A With Inhibitors in Spain by Multi-Criteria Decision Analysis”. Global and Regional Health Technology Assessment, vol. 6, no. 1, Oct. 2019, doi:10.33393/grhta.2019.452.